by synergycap1 | Apr 22, 2017 | Bad Credit Loans, Bank Lending, Business Loans, Capital, Non-Bank Loans, Working Capital
We’re getting closer to graduation day for many students across America. Amid feelings of excitement, anxiety and confusion, these new graduates will be thrust into a decision to figure out the next chapter of their lives. That can be easier said than done. If...
by synergycap1 | Apr 22, 2017 | Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Capital, Economics, Finance, Non-Bank Loans, Working Capital
(Image: iStock/TSnowImages) For entrepreneurs, extreme weather, sea level rise, and local pollution choke more than the health of our families; they choke our businesses, and they choke economic opportunity for people of color. As the leader of an organization that...
by synergycap1 | Apr 22, 2017 | Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Capital, Economics, Finance, Non-Bank Loans, Working Capital
The European Central Bank has decided on interest rates and bond purchases for the rest of 2017 and will decide what to do beyond that in the second half of this year, ECB Governing Council member Ewald Nowotny said in an interview published on Saturday....
by synergycap1 | Apr 22, 2017 | Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Capital, Economics, Finance, Non-Bank Loans, Working Capital
For Grishma, an Indian software designer, President Donald Trump’s review of the visa program for bringing highly skilled workers into the United States comes at a bad time. Fresh from gaining a master’s degree in Europe, and with an offer of employment...
by synergycap1 | Apr 22, 2017 | Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Capital, Economics, Finance, Non-Bank Loans, Working Capital
U.S. Vice President Mike Pence said on Saturday the United States would honor a controversial refugee deal with Australia, under which the United States would resettle 1,250 asylum seekers, a deal President Donald Trump had described as “dumb.” Pence told...
by synergycap1 | Apr 22, 2017 | Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Capital, Economics, Finance, Non-Bank Loans, Working Capital
South Korea’s Samsung Bioepis has won a U.S. FDA nod for a biosimilar of Johnson & Johnson’s Remicade, marking a first for the company in the U.S. and setting up a path to competition with the world’s largest drug company and a similar product...
